| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |